Logo image of DEX.DE

DELTICOM AG (DEX.DE) Stock Fundamental Analysis

FRA:DEX - Deutsche Boerse Ag - DE0005146807 - Common Stock - Currency: EUR

2.3  +0.06 (+2.68%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to DEX. DEX was compared to 55 industry peers in the Specialty Retail industry. DEX has an excellent profitability rating, but there are concerns on its financial health. DEX scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

DEX had positive earnings in the past year.
DEX had a positive operating cash flow in the past year.
Of the past 5 years DEX 4 years were profitable.
In multiple years DEX reported negative operating cash flow during the last 5 years.
DEX.DE Yearly Net Income VS EBIT VS OCF VS FCFDEX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

DEX has a Return On Assets of 3.44%. This is in the better half of the industry: DEX outperforms 70.91% of its industry peers.
Looking at the Return On Equity, with a value of 16.71%, DEX belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 14.13%, DEX belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DEX is in line with the industry average of 11.82%.
The last Return On Invested Capital (14.13%) for DEX is above the 3 year average (13.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.44%
ROE 16.71%
ROIC 14.13%
ROA(3y)2.91%
ROA(5y)-1.69%
ROE(3y)14.06%
ROE(5y)-74.82%
ROIC(3y)13.71%
ROIC(5y)N/A
DEX.DE Yearly ROA, ROE, ROICDEX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

DEX's Profit Margin of 1.60% is fine compared to the rest of the industry. DEX outperforms 63.64% of its industry peers.
DEX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 3.23%, DEX is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
DEX's Operating Margin has improved in the last couple of years.
DEX has a worse Gross Margin (28.50%) than 60.00% of its industry peers.
In the last couple of years the Gross Margin of DEX has grown nicely.
Industry RankSector Rank
OM 3.23%
PM (TTM) 1.6%
GM 28.5%
OM growth 3Y1.64%
OM growth 5Y38.53%
PM growth 3Y10.82%
PM growth 5YN/A
GM growth 3Y1.63%
GM growth 5Y1.75%
DEX.DE Yearly Profit, Operating, Gross MarginsDEX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DEX is creating value.
DEX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, DEX has more shares outstanding
DEX has a better debt/assets ratio than last year.
DEX.DE Yearly Shares OutstandingDEX.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
DEX.DE Yearly Total Debt VS Total AssetsDEX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.50 indicates that DEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.50, DEX is doing good in the industry, outperforming 74.55% of the companies in the same industry.
The Debt to FCF ratio of DEX is 13.08, which is on the high side as it means it would take DEX, 13.08 years of fcf income to pay off all of its debts.
DEX has a Debt to FCF ratio (13.08) which is comparable to the rest of the industry.
DEX has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of DEX (1.00) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 13.08
Altman-Z 2.5
ROIC/WACC2.61
WACC5.42%
DEX.DE Yearly LT Debt VS Equity VS FCFDEX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

DEX has a Current Ratio of 0.89. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
DEX's Current ratio of 0.89 is on the low side compared to the rest of the industry. DEX is outperformed by 80.00% of its industry peers.
A Quick Ratio of 0.30 indicates that DEX may have some problems paying its short term obligations.
DEX has a Quick ratio of 0.30. This is in the lower half of the industry: DEX underperforms 78.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.3
DEX.DE Yearly Current Assets VS Current LiabilitesDEX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 185.45% over the past year.
Measured over the past 5 years, DEX shows a small growth in Earnings Per Share. The EPS has been growing by 0.27% on average per year.
Looking at the last year, DEX shows a decrease in Revenue. The Revenue has decreased by -7.37% in the last year.
The Revenue has been decreasing by -5.96% on average over the past years.
EPS 1Y (TTM)185.45%
EPS 3Y0.27%
EPS 5YN/A
EPS Q2Q%-96.06%
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y-4.33%
Revenue growth 5Y-5.96%
Sales Q2Q%3.4%

3.2 Future

Based on estimates for the next years, DEX will show a very strong growth in Earnings Per Share. The EPS will grow by 42.03% on average per year.
Based on estimates for the next years, DEX will show a small growth in Revenue. The Revenue will grow by 1.43% on average per year.
EPS Next Y56.76%
EPS Next 2Y48.87%
EPS Next 3Y42.03%
EPS Next 5YN/A
Revenue Next Year-4.32%
Revenue Next 2Y-0.76%
Revenue Next 3Y0.6%
Revenue Next 5Y1.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DEX.DE Yearly Revenue VS EstimatesDEX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
DEX.DE Yearly EPS VS EstimatesDEX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4

9

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.26 indicates a rather cheap valuation of DEX.
Compared to the rest of the industry, the Price/Earnings ratio of DEX indicates a rather cheap valuation: DEX is cheaper than 98.18% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.63, DEX is valued rather cheaply.
A Price/Forward Earnings ratio of 5.55 indicates a rather cheap valuation of DEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DEX indicates a rather cheap valuation: DEX is cheaper than 90.91% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.72, DEX is valued rather cheaply.
Industry RankSector Rank
PE 4.26
Fwd PE 5.55
DEX.DE Price Earnings VS Forward Price EarningsDEX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

83.64% of the companies in the same industry are more expensive than DEX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DEX is valued a bit cheaper than 74.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.82
EV/EBITDA 4.01
DEX.DE Per share dataDEX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

DEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DEX may justify a higher PE ratio.
A more expensive valuation may be justified as DEX's earnings are expected to grow with 42.03% in the coming years.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y48.87%
EPS Next 3Y42.03%

0

5. Dividend

5.1 Amount

No dividends for DEX!.
Industry RankSector Rank
Dividend Yield N/A

DELTICOM AG

FRA:DEX (3/21/2025, 7:00:00 PM)

2.3

+0.06 (+2.68%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-12 2024-11-12
Earnings (Next)03-27 2025-03-27/amc
Inst Owners22.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap34.11M
Analysts80
Price Target4.25 (84.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.83%
Valuation
Industry RankSector Rank
PE 4.26
Fwd PE 5.55
P/S 0.07
P/FCF 5.82
P/OCF 2.74
P/B 0.71
P/tB 3.12
EV/EBITDA 4.01
EPS(TTM)0.54
EY23.48%
EPS(NY)0.41
Fwd EY18%
FCF(TTM)0.4
FCFY17.19%
OCF(TTM)0.84
OCFY36.44%
SpS33.91
BVpS3.24
TBVpS0.74
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.44%
ROE 16.71%
ROCE 16.87%
ROIC 14.13%
ROICexc 14.69%
ROICexgc 24.51%
OM 3.23%
PM (TTM) 1.6%
GM 28.5%
FCFM 1.17%
ROA(3y)2.91%
ROA(5y)-1.69%
ROE(3y)14.06%
ROE(5y)-74.82%
ROIC(3y)13.71%
ROIC(5y)N/A
ROICexc(3y)14.55%
ROICexc(5y)N/A
ROICexgc(3y)25.91%
ROICexgc(5y)N/A
ROCE(3y)16.38%
ROCE(5y)N/A
ROICexcg growth 3Y-28.6%
ROICexcg growth 5YN/A
ROICexc growth 3Y-14.32%
ROICexc growth 5Y15.18%
OM growth 3Y1.64%
OM growth 5Y38.53%
PM growth 3Y10.82%
PM growth 5YN/A
GM growth 3Y1.63%
GM growth 5Y1.75%
F-Score7
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 13.08
Debt/EBITDA 1.8
Cap/Depr 62.59%
Cap/Sales 1.31%
Interest Coverage 6.53
Cash Conversion 46.49%
Profit Quality 73.04%
Current Ratio 0.89
Quick Ratio 0.3
Altman-Z 2.5
F-Score7
WACC5.42%
ROIC/WACC2.61
Cap/Depr(3y)32.35%
Cap/Depr(5y)26.39%
Cap/Sales(3y)0.59%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.45%
EPS 3Y0.27%
EPS 5YN/A
EPS Q2Q%-96.06%
EPS Next Y56.76%
EPS Next 2Y48.87%
EPS Next 3Y42.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y-4.33%
Revenue growth 5Y-5.96%
Sales Q2Q%3.4%
Revenue Next Year-4.32%
Revenue Next 2Y-0.76%
Revenue Next 3Y0.6%
Revenue Next 5Y1.43%
EBIT growth 1Y23.24%
EBIT growth 3Y-2.76%
EBIT growth 5Y30.27%
EBIT Next Year241.25%
EBIT Next 3Y63.6%
EBIT Next 5YN/A
FCF growth 1Y-76.08%
FCF growth 3Y-7.15%
FCF growth 5YN/A
OCF growth 1Y-52.76%
OCF growth 3Y-2.7%
OCF growth 5YN/A